Differential receptor binding properties of erythropoietin (Epo) monomer and an Epo-Epo fusion protein.

被引:0
|
作者
Harrahy, JJ [1 ]
Feldman, L [1 ]
Sytkowski, AJ [1 ]
机构
[1] Beth Israel Deaconess Med Ctr, Mol Cell Biol Lab, Boston, MA 02215 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
4365
引用
收藏
页码:153B / 153B
页数:1
相关论文
共 50 条
  • [41] A DOMINANT-NEGATIVE ERYTHROPOIETIN (EPO) RECEPTOR INHIBITS EPO-DEPENDENT GROWTH AND BLOCKS F-GP55-DEPENDENT TRANSFORMATION
    BARBER, DL
    DEMARTINO, JC
    SHOWERS, MO
    DANDREA, AD
    MOLECULAR AND CELLULAR BIOLOGY, 1994, 14 (04) : 2257 - 2265
  • [42] ANTIERYTHROPOIETIN RECEPTOR (EPO-R) MONOCLONAL-ANTIBODIES INHIBIT ERYTHROPOIETIN BINDING AND NEUTRALIZE BIOACTIVITY
    DANDREA, AD
    RUP, BJ
    FISHER, MJ
    JONES, S
    BLOOD, 1993, 82 (01) : 46 - 52
  • [43] Regulation of human beta spectrin I pre-mRNA processing by erythropoietin (Epo) correlates with Epo-stimulated changes in SR protein phosphorylation in UT-7/Epo cells.
    Chu, ZL
    Komatsu, N
    Winkelmann, JC
    BLOOD, 1995, 86 (10) : 1649 - 1649
  • [44] Erythropoietin receptor (EPO-R) expression and localization in breast cancer cells is associated with EPO-mediated protection against cytotoxic treatment
    Hedley, Benjamin D.
    Chu, Jenny
    Ormond, George
    Allan, Alison L.
    Xenocostas, Anargyros
    CLINICAL & EXPERIMENTAL METASTASIS, 2009, 26 (07) : 852 - 852
  • [45] Regulation of Erythropoietin Receptor Activity in Endothelial Cells by Different Erythropoietin (EPO) Derivatives: An in Vitro Study
    Trincavelli, Maria Letizia
    Da Pozzo, Eleonora
    Ciampi, Osele
    Cuboni, Serena
    Daniele, Simona
    Abbracchio, Maria Pia
    Martini, Claudia
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2013, 14 (02): : 2258 - 2281
  • [46] THE ROLE OF PROTEIN-KINASE-C (PKC) IN THE REGULATION OF ERYTHROPOIETIN (EPO) PRODUCTION
    YANG, TX
    OHIGASHI, T
    FISHER, JW
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1994, 5 (03): : 675 - 675
  • [47] The C-terminus of C-ABL is required for proliferation and viability signalling in a C-ABL/EPO receptor fusion protein.
    Okuda, K
    VanEtten, R
    DAndrea, A
    Griffin, JD
    BLOOD, 1997, 90 (10) : 1100 - 1100
  • [48] Structural Identification of Modified Amino Acids on the Interface between EPO and Its Receptor from EPO BRP, Human Recombinant Erythropoietin by LC/MS Analysis
    Song, Kwang-Eun
    Byeon, Jaehee
    Moon, Dae-Bong
    Kim, Hyong-Ha
    Choi, Yoo-Joo
    Suh, Jung-Keun
    MOLECULES AND CELLS, 2014, 37 (11) : 819 - 826
  • [49] Cause and Timing of Death and Subgroup Differential Effects of Erythropoietin in the EPO-TBI Study
    Skrifvars, Markus B.
    French, Craig
    Bailey, Michael
    Presneill, Jeffrey
    Nichol, Alistair
    Little, Lorraine
    Durantea, Jacques
    Huet, Olivier
    Haddad, Samir
    Arabi, Yaseen
    McArthur, Colin
    Cooper, D. James
    Bellomo, Rinaldo
    JOURNAL OF NEUROTRAUMA, 2018, 35 (02) : 333 - 340
  • [50] Erythropoietin (EPO)-receptor signaling induces cell death of primary myeloma cells in vitro
    Vatsveen, Thea Kristin
    Sponaas, Anne-Marit
    Tian, Erming
    Zhang, Qing
    Misund, Kristine
    Sundan, Anders
    Borset, Magne
    Waage, Anders
    Brede, Gaute
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2016, 9